Developing effective vaccines against a deadly global pandemic is certainly bullish for a stock. Indeed, Moderna and Pfizer shareholders have put away as much as 516% and 51% gains, respectively. And when a lot of investors see this, they fear they’ve missed out. Well, Michael’s here to assure you that you haven’t; not by a long shot. And today, he’s got a vaccine stock you should put at the top of your “must-buy” list for the week ahead… . Read more... Tags: Stocks to Buy The post This COVID-19 Vaccine Stock Has More Upside Than Pfizer or Moderna appeared first on Money Morning - We Make Investing Profitable .